Advertisement

Alkalies

You have accessRestricted Access
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan
Matteo Bargagli, Nasser A. Dhayat, Manuel Anderegg, Mariam Semmo, Uyen Huynh-Do, Bruno Vogt, Pietro Manuel Ferraro and Daniel G. Fuster

CJASN July 2020, 15 (7) 1007-1014; DOI: https://doi.org/10.2215/CJN.13861119

Add to Selected Citations
You have accessRestricted Access
Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease–Related Medications in Veterans
Shen Song, I-Chun Thomas, Calyani Ganesan, Ericka M. Sohlberg, Glenn M. Chertow, Joseph C. Liao, Simon Conti, Christopher S. Elliott, Alan C. Pao and John T. Leppert

CJASN December 2019, 14 (12) 1773-1780; DOI: https://doi.org/10.2215/CJN.03580319

Add to Selected Citations
Open Access
Effects of Treatment of Metabolic Acidosis in CKD
Sankar D. Navaneethan, Jun Shao, Jerry Buysse and David A. Bushinsky

CJASN July 2019, 14 (7) 1011-1020; DOI: https://doi.org/10.2215/CJN.13091118

Add to Selected Citations
You have accessRestricted Access
Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD
Jessica Kendrick, Pratik Shah, Emily Andrews, Zhiying You, Kristen Nowak, Andreas Pasch and Michel Chonchol

CJASN October 2018, 13 (10) 1463-1470; DOI: https://doi.org/10.2215/CJN.00380118

Add to Selected Citations